<DOC>
	<DOCNO>NCT02543034</DOCNO>
	<brief_summary>This study randomize , control , multi-centre , open-label , phase IV study . Total 81 patient enrol study . Patients randomly assign Betafoam® , petrolatum gauze Allevyn donor site wound skin graft operation .</brief_summary>
	<brief_title>Study Petrolatum Gauze , Allevyn , New Antiseptic Dressing , Betafoam® Dressing , Management Split-Thickness Skin Graft Donor Site</brief_title>
	<detailed_description />
	<mesh_term>Anti-Infective Agents , Local</mesh_term>
	<mesh_term>Petrolatum</mesh_term>
	<criteria>1 . Patients 19 year old 2 . Patients receive elective skin harvest operation 3 . Patients lateral thigh buttock donor site area 50 150 cm2 4 . Female patient use method contraception study 5 . Patients voluntarily sign informed consent 1 . Patients pregnant 2 . Patients know allergy dress product include PVPI 3 . Known hyperthyroidism thyroid dysfunction nodular thyroid goiter , endemic goiter Hashimoto 's thyroiditis patient receive radioiodine therapy 4 . Comorbidities may adversely affect wound heal example patient uncontrolled diabetes ( HbA1c &gt; 8 % ) , chronic renal failure , autoimmune disease , immunocompromised patient 5 . Patients receive anticoagulant , steroid immunosuppressant 6 . Patients sign symptom infection enrollment adversely affect wound heal 7 . Patients skin lesion Herpes zoster donor site 8 . Burn &gt; 20 % total body surface area 9 . If donor site harvest previous occasion 10 . Patients limited cognitive ability 11 . Patients participate plan participate clinical trial 12 . Other various condition investigator judge inappropriate enrolment</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>